S1PR3 and breast carcinoma: The action of vitamin D on sphingolipids may even be opposite in different districts, suggesting responses specific to particular cell types (e.g., the difference in the gene expression of sphingosine 1-phosphate receptor 3 (S1P3) between monocytes and human breast cancer cells) [46,47].